Metlife (MET) Other financing activities (2009 - 2026)

Metlife has reported Other financing activities for 18 years, with the latest figure at $119.0 million in Q2 2026.

• On a quarterly basis, Other financing activities rose 471.88% year-over-year to $119.0 million in Q2 2026; TTM through Jun 2026 was $22.0 million, a 116.3% increase from a year earlier, with the FY2025 full-year figure at -$261.0 million, down 217.04% from the prior year.
• Other financing activities was $119.0 million for Q2 2026 at Metlife, up from -$67.0 million in the prior quarter.
• The five-year high for Other financing activities was $166.0 million in Q2 2024, with the low at -$199.0 million in Q1 2025.
• Average Other financing activities over 5 years is -$20.1 million, with a median of -$31.0 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Other financing activities tumbled 1600.0% in 2022, then surged 471.88% in 2026.
• Over 5 years, Other financing activities stood at -$30.0 million in 2022, then sank by 40.0% to -$42.0 million in 2023, then jumped by 297.62% to $83.0 million in 2024, then slumped by 155.42% to -$46.0 million in 2025, then jumped by 358.7% to $119.0 million in 2026.
• The last three Other financing activities figures came in at $119.0 million (Q2 2026), -$67.0 million (Q1 2026), and -$46.0 million (Q4 2025), per Business Quant data.